Stock screenerAll disclosures →
EDGAR →
GSK
Conviction 27HealthcareScan · Thu, Jun 25, 2026Gravestone doji
GSK$51.88+1.55%
ResistanceSupportVol 14Congress buyCongress sellVol MA14 4.17M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price51.88
Change+1.55%
Gap+1.64%
Rel volume0.88×
Avg volume3.99M
Avg $ vol204.5M
SMA 2051.23
SMA 5052.09
SMA 20050.31
Price vs 50-0.39%
Price vs 200+3.12%
MA stackmixed
50/200 cross—
Supertrendup · 50.16
RSI (14)52
MACD hist0.08
MACD cross—
Stoch %K / %D49 / 46
ADX (14)15
+DI / −DI25 / 28
RSI divergence—
MACD divergence—
ATR %+2.07%
ADR %1.63%
52w high61.18
52w low36.20
From 52w high-15.20%
Above 52w low+43.31%
New 52w highNo
SqueezeOff
Bollinger width8.25%
%B0.65
Donchian pos67.83%
Donchian high53.45
Donchian low48.57
AVWAP (52w high)54.13
vs AVWAP high-4.16%
AVWAP (52w low)48.61
vs AVWAP low+6.73%
OBV trendFlat
Chaikin MF (20)-0.22
Today vs 20d0.88×
Avg vol (14d)4.17M
Avg vol (20d)3.99M
Avg $ vol (20d)204.5M
Market cap223.89B
RS 3m (vs SPY)-15.77%
RS 6m (vs SPY)-2.63%
RS line new highNo
Trend template4/8
Technical rank56.2
1 week-0.52%
1 month+0.74%
3 months-5.16%
6 months+6.77%
1 year+34.13%
YTD+4.53%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target63.70
Target upside22.78%
Analyst ratingBuy
Institutional18.65%
Ent. value223.89B
Revenue—
Net income—
Gross profit—
Free cash flow—
IndustryDrug Manufacturers - General
ExchangeNYSE
Shares out2.03B
Employees66.84K
ListedWed, Aug 18, 1976
Free float1.95B
Float %97.1%
Short interest9.77M
Days to cover3.2d
Short volume50.5%
Squeeze score24 / 100
Next earningsWed, Jul 29, 2026 (34d)
EPS forecast$1.27 · 5 est
Last EPS vs est$1.24 vs $1.17
Last surprise+6.0% beat
Setup gradeD
Conviction27 / 100
Pattern quality—
Tech rank56.2 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmGravestone doji
News sentiment—
Congress activity
Disclosed STOCK Act trades in GSK · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Lisa McClain house · MI · traded 2025-10-31 | Sell | $1K–$15K | 2025-10-31 | 2025-11-01 | |
Lisa McClain house · MI · traded 2025-10-30 | Sell | $1K–$15K | 2025-10-30 | 2025-11-01 | |
 Valerie Hoyle house · D · OR · traded 2025-09-23 | Sell | $1K–$15K | 2025-09-23 | 2025-10-10 | |
Valerie Hoyle house · D · OR · traded 2024-11-18 | Buy | $1K–$15K | 2024-11-18 | 2025-09-12 | |
Lisa McClain house · R · MI · traded 2025-08-04 | Buy | $1K–$15K | 2025-08-04 | 2025-09-12 | |
 Robert B. Aderholt house · R · AL · traded 2025-07-28 | Sell | $1K–$15K | 2025-07-28 | 2025-09-10 | |
Lisa McClain house · R · MI · traded 2025-06-24 | Sell | $1K–$15K | 2025-06-24 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-06-17 | Buy | $1K–$15K | 2025-06-17 | 2025-08-13 | |
 Bruce Westerman house · R · AR · traded 2025-04-21 | Sell | $1K–$15K | 2025-04-21 | 2025-05-12 | |
Bruce Westerman house · R · AR · traded 2025-03-03 | Buy | $1K–$15K | 2025-03-03 | 2025-04-16 |
Insider activity
SEC Form 4 transactions in GSK
No recent insider (Form 4) filings in GSK. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in GSK · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.